MichaelWayneBoyerMD
Pediatric Hematology & Oncology • Salt Lake City, UTDirector Blood and Marrow Transplant University of Utah
Dr. Boyer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
100 N Mario Capecchi Dr
Salt Lake City, UT 84113Phone+1 801-662-4700Fax+1 801-585-3432- Is this information wrong?
Education & Training
University of MinnesotaFellowship, Pediatric Hematology/Oncology, 1991 - 1995- University of MinnesotaResidency, Pediatrics, 1987 - 1990
Indiana University School of MedicineClass of 1987
Certifications & Licensure
UT State Medical License 2006 - 2026
OH State Medical License 2000 - 2007
GA State Medical License 1995 - 2001
MN State Medical License 1991 - 1996- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
- Phase I/II Study of Treg/Tcon Addback to Partially Matched Related Donor Stem Cells With Myeloablative Conditioning and Post-transplant Cyclophosphamide for High Risk Hematologic Malignancies Start of enrollment: 2013 Jul 12
- Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients Start of enrollment: 2015 Apr 08
Publications & Presentations
PubMed
- 53 citationsThree-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial.Theodore W Laetsch, Shannon L Maude, Susana Rives, Hidefumi Hiramatsu, Henrique Bittencourt, Peter Bader, André Baruchel, Michael Boyer, Barbara De Moerloose, Muna Qay...> ;Journal of Clinical Oncology. 2023 Mar 20
- Successful administration of CD19 chimeric antigen receptor T cells in association with severe cyanotic congenital heart disease.Ambur Staab, Lindsey Gakenheimer-Smith, Michael Boyer, Andrew Harris, Zeinab Afify> ;Pediatric Blood & Cancer. 2022 Jun 1
- 51 citationsNext-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic LeukemiaMichael A. Pulsipher, Xia Han, Shannon L. Maude, Theodore W. Laetsch, Muna Qayed, Susana Rives, Michael Boyer, Hidefumi Hiramatsu, Gregory A. Yanik, Timothy A. Driscol...> ;Blood Cancer Discovery. 2021 Dec 1
- Join now to see all
Journal Articles
- Genetic Mechanisms of Target Antigen Loss in CAR19 Therapy of Acute Lymphoblastic LeukemiaJohn E Levine, Muna Qayed, Stephan A Grupp, Eneida R Nemecek, Stella M Davies, Michael R Verneris, Michael Boyer, Jeffrey A Engelman, Nature
- Clinical Pharmacology of Tisagenlecleucel in B-cell Acute Lymphoblastic LeukemiaMichael W Boyer, Bruce L Levine, Carl H June, Theodore W Laetsch, Clinical Cancer Research
Hospital Affiliations
Primary Children's HospitalSalt Lake City, Utah
University of Utah HealthSalt Lake City, Utah
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
